Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
TATA Health International Holdings Ltd. ( (HK:1255) ) just unveiled an update.
TATA Health International Holdings Limited has announced the current composition of its board of directors, listing one executive director who also serves as chief executive officer, one non-executive director and four independent non-executive directors. The disclosure also details the structure of three key board committees — audit, remuneration and nomination — and assigns chairmanship and memberships, underscoring the company’s corporate governance framework and oversight mechanisms for shareholders and regulators.
The audit committee is chaired by independent non-executive director Tan Kaiguo, with Li Liang and Du Jianfeng as members, while the remuneration and nomination committees are both chaired by independent non-executive director Huang Lin and include Li Liang and Du Jianfeng. This configuration highlights a strong role for independent directors in supervising financial reporting, executive pay and board appointments, which may bolster investor confidence in governance standards at the Hong Kong-listed healthcare group.
More about TATA Health International Holdings Ltd.
TATA Health International Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 1255. The company operates in the healthcare sector, though the specific products and services are not detailed in this release, and is governed by a board comprising executive, non-executive and independent non-executive directors.
Average Trading Volume: 80,693
Technical Sentiment Signal: Buy
Current Market Cap: HK$376.4M
See more data about 1255 stock on TipRanks’ Stock Analysis page.